BR112022022615A2 - Proteína nova e usos terapêuticos e cosméticos da mesma - Google Patents
Proteína nova e usos terapêuticos e cosméticos da mesmaInfo
- Publication number
- BR112022022615A2 BR112022022615A2 BR112022022615A BR112022022615A BR112022022615A2 BR 112022022615 A2 BR112022022615 A2 BR 112022022615A2 BR 112022022615 A BR112022022615 A BR 112022022615A BR 112022022615 A BR112022022615 A BR 112022022615A BR 112022022615 A2 BR112022022615 A2 BR 112022022615A2
- Authority
- BR
- Brazil
- Prior art keywords
- therapeutic
- cosmetic uses
- same
- proteins
- new protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Cell Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
Abstract
PROTEÍNA NOVA E USOS TERAPÊUTICOS E COSMÉTICOS DA MESMA. A presente invenção provê uma nova proteína e fragmentos biologicamente ativos e variantes dos mesmos com usos terapêuticos e cosméticos vantajosos. Também são providos métodos de uso das proteínas, assim como métodos de produção as proteínas usando uma célula recombinante. São providas adicionalmente células hospedeiras recombinantes transformadas com uma sequência de polinucleotídeos que codifica a expressão das proteínas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063020860P | 2020-05-06 | 2020-05-06 | |
PCT/US2021/031047 WO2021226318A1 (en) | 2020-05-06 | 2021-05-06 | Novel protein, and therapeutic and cosmetic uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022022615A2 true BR112022022615A2 (pt) | 2022-12-20 |
Family
ID=78468383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022022615A BR112022022615A2 (pt) | 2020-05-06 | 2021-05-06 | Proteína nova e usos terapêuticos e cosméticos da mesma |
Country Status (11)
Country | Link |
---|---|
US (1) | US20230357332A1 (pt) |
EP (1) | EP4146671A1 (pt) |
JP (1) | JP2023524765A (pt) |
KR (1) | KR20230035231A (pt) |
CN (1) | CN115776986A (pt) |
AU (1) | AU2021268961A1 (pt) |
BR (1) | BR112022022615A2 (pt) |
CA (1) | CA3176797A1 (pt) |
IL (1) | IL297385A (pt) |
MX (1) | MX2022013737A (pt) |
WO (1) | WO2021226318A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3156574A1 (en) * | 2019-11-26 | 2021-09-30 | Quorum Innovations, Llc | Novel protective barrier compositions, and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7381555B2 (en) * | 2001-09-14 | 2008-06-03 | Institut Pasteur | Lactobacillus N-deoxyribosyl transferases, corresponding nucleotide sequences and their uses |
US9416354B1 (en) * | 2015-02-24 | 2016-08-16 | The United States Of America, As Represented By The Secretary Of Agriculture | Ferulate esterase isolated from Lactobaccillus fermentum |
MX2018000870A (es) * | 2015-07-20 | 2018-05-15 | Quorum Innovations Llc | Metodos y materiales para mejorar las respuestas inmunitarias y funciones de la barrera de piel y/o mucosa. |
-
2021
- 2021-05-06 EP EP21800137.8A patent/EP4146671A1/en active Pending
- 2021-05-06 MX MX2022013737A patent/MX2022013737A/es unknown
- 2021-05-06 IL IL297385A patent/IL297385A/en unknown
- 2021-05-06 JP JP2022567235A patent/JP2023524765A/ja active Pending
- 2021-05-06 CN CN202180033675.4A patent/CN115776986A/zh active Pending
- 2021-05-06 US US17/312,484 patent/US20230357332A1/en active Pending
- 2021-05-06 BR BR112022022615A patent/BR112022022615A2/pt unknown
- 2021-05-06 CA CA3176797A patent/CA3176797A1/en active Pending
- 2021-05-06 AU AU2021268961A patent/AU2021268961A1/en active Pending
- 2021-05-06 WO PCT/US2021/031047 patent/WO2021226318A1/en unknown
- 2021-05-19 KR KR1020227041647A patent/KR20230035231A/ko active Search and Examination
Also Published As
Publication number | Publication date |
---|---|
CA3176797A1 (en) | 2021-11-11 |
EP4146671A1 (en) | 2023-03-15 |
WO2021226318A1 (en) | 2021-11-11 |
IL297385A (en) | 2022-12-01 |
CN115776986A (zh) | 2023-03-10 |
KR20230035231A (ko) | 2023-03-13 |
AU2021268961A1 (en) | 2022-11-17 |
MX2022013737A (es) | 2022-11-16 |
US20230357332A1 (en) | 2023-11-09 |
JP2023524765A (ja) | 2023-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112022016550A2 (pt) | Proteínas de ligação a flt3 e métodos de uso | |
BR112021022874A2 (pt) | Proteínas de ligação epcam e métodos de uso | |
BR112012006501A8 (pt) | Polipeptídios e usos dos mesmos | |
BRPI0508455A (pt) | muteìnas de interleucina-2 combinatórias | |
BR112021005769A2 (pt) | proteínas de ligação a dll3 e métodos de uso | |
EA201170993A1 (ru) | Удлиненные рекомбинантные полипептиды и содержащие их композиции | |
AR032743A1 (es) | Composiciones y metodos para la terapia y el diagnostico de cancer de pulmon | |
CY1108459T1 (el) | Ακτ-3 νουκλεϊκα οξεα, πολυπεπτιδια, και χρησεις αυτων | |
BR112021024786A2 (pt) | Construção de rna, sequência de ácido nucleico, cassete de expressão, vetor recombinante, composição farmacêutica, método para preparar a construção de rna, vacina, método para modificar uma célula ex vivo ou in vitro e célula modificada | |
DE3880739D1 (de) | Expression von menschlichem proapolipoprotein a-1. | |
AR080229A1 (es) | Proteinas de dominio de armazon de fibronectina que se unen a il -23 (interleucina 23) | |
AR072531A1 (es) | SENAL DE POLIADENILACIoN | |
BR112022011975A2 (pt) | Polipeptídeo de interferon-¿2 modificado, polipeptídeo gmop-interferon-¿2 modificado, ácido nucleico, plasmídeo, vetor, linha de célula, método para purificação do polipeptídeo de interferon-¿2 modificado, composição farmacêutica, método para uso de um ou mais dos polipeptídeos de interferon-¿2 modificados e método para tratar uma condição médica em um indivíduo | |
BR112022022615A2 (pt) | Proteína nova e usos terapêuticos e cosméticos da mesma | |
BR112022001359A2 (pt) | Método e composição para anticorpos anti-cd73 e variantes | |
BRPI0515893B8 (pt) | peptídeos da proteína humana de estresse térmico, composição farmacêutica, e, uso do peptídeo e da composição farmacêutica. | |
KR870003792A (ko) | 백혈구 감소증치료제 | |
BR112021019109A2 (pt) | Célula rpe manipulada, composições, molécula isolada de dna de fita dupla, dispositivo implantável, cápsula de hidrogel, e, método para aplicar uma terapia com fvii | |
BR112023003526A2 (pt) | Proteínas de fusão de coronavírus imunogênicos e métodos relacionados | |
ES2058486T3 (es) | Inmunogenos nativos y recombinantes del grupo b de eimeria tenella utiles como vacunas para las coccidiosis. | |
BR112021019139A2 (pt) | Célula de mamífero manipulada, composição, molécula isolada de dna de fita dupla, dispositivo implantável, cápsula de hidrogel, e, método de tratamento de um paciente com doença de fabry | |
BR112022006842A2 (pt) | Construtos de igf2 variante | |
BR112022003633A2 (pt) | Métodos para produção de arginase 1 recombinante humana e usos da mesma | |
BR112021017853A2 (pt) | Vetores de dna não virais e usos dos mesmos para expressar terapêuticas de fviii | |
BR112023022421A2 (pt) | Composições de colágeno e métodos de uso das mesmas |